Utah Supreme Court Allows Lawsuit for Psychotropic-Induced Murder
Ruling that health care providers, while important, "are not entitled to an elevated status in tort law that would categorically immunize them from liability...
Abbott to Pay $700 Million for Off-Label Marketing of Depakote
Pleading guilty to marketing Depakote for behavioral problems in dementia patients, a purpose for which the drug was not approved, a federal judge has...
Freud in the Scanner: A Revival of Interest in Introspection
FromĀ Aeon: For the past several decades, mainstream mental health professionals as well as the general public have dismissed Freud's ideas, turning instead to neuroscience...
“Substantial” Relapse After ECT, With or Without Medication
The Journal of ECT, looking at the question of whether antidepressant medications at the start of ECT reduced post-ECT relapse in a sample of...
“Mental Illness Plagued Student Who Leaped From Niagara Falls”
Greg Young, who leapt to his death from the top of Niagara Falls, "had been on numerous medications, all of which came with warnings...
Janssen to Pay $11M for Failure to Warn of Topamax Birth Defects
A Philadelphia jury yesterday orderedĀ Johnson & Johnson subsidiary Janssen to pay $11 million to the parents of a five-year-old boy for failure to warn...
Abbott to Pay $1.6 Billion for “Elder Abuse”, Off-Label Marketing
Abbott Laboratories has pled guilty to civil and criminal charges of illegally marketing Depakote for the control of agitation and aggression in elderly patients...
Missouri Sued for Over-Drugging Foster Children
FromĀ Reuters: Two youth legal advocacy groups have filed a lawsuit against Missouri for over-exposing foster children to psychotropic drugs. The lawsuit seeks a court...
Lowering the Threshold for Bipolar: “More Harm Than Good”
Researchers publishing in the Journal of Clinical Psychiatry argue that broadening the diagnostic criteria for bipolar disorder would result in a greater increase in...
Might Antidepressants Create Treatment Resistance?
FromĀ Psychiatric Times: A recent study of individualsĀ diagnosed with bipolar II disorder found that patients who haveĀ taken antidepressants in the past areĀ less likely to respond...
Pfizer Loses Appeal of Neurontin
On Monday the U.S. Supreme Court rejected Pfizer's appeal of a $142 million award to the Kaiser Foundation for illegal marketing of Neurontin. Ā The...
Sexual Side Effects of Medications in Young People
The effects of antidepressants and mood stabilizers on young people's psychosexual development receive little attention or research, says Kaitlin Bell Barnett (author of "Dosed:...
The $3 Billion Research Breakdown
In this piece for Medscape, Jodi S. CohenĀ chronicles the research malpractice case of child psychiatrist Mani Pavuluri, who put vulnerable children at serious risk...
Call for an Investigation Into Psych Meds and Violence
The killing of 20 children and six adults in Newtown has triggered a search for some way of preventing these kinds of tragedies.Ā The...
Pfizer to Pay $325M for False Neurontin Marketing
After ten years of litigation, Pfizer has agreed to pay $325 million for marketing its anticonvulsant Neurontin for unapproved purposes. Ā The settlement comes six...
Nevada Legislation Aims to Curb Psychotropics in Foster Children
A touching article in the Las Vegas Sun follows one child from abandonment through foster placements, polypharmacy, suicidality, delinquency and homelessness to stability off...
āFDA Forced to Release Adverse Event Reports on Psychiatric Drugsā
Following a lawsuit brought by Andrew Thibault of Parents Against Pharmaceutical Abuse (PAPA), the FDA has produced adverse event and severe adverse event reports...
The Issue of Over-Diagnosing in Psychiatry
FromĀ The Concordian: On October 30th, Dr. Joel Paris, a professor of psychiatry at McGill University, gave a lecture about the dangers and consequences of...
